We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian public assessment report (AusPar)AVTOZMA (tocilizumab), a biosimilar to ACTEMRA, has been approved to treat multiple autoimmune and inflammatory conditions.
-
-